# K222792: SNUCONE Tissue Level Implant System

- Pathway: 510(k) (Traditional)
- Applicant: Snucone Co., Ltd.
- Decided: Jun 8, 2023 after 265 days
- Product code: DZE (Implant, Endosseous, Root-Form)
- Device class: 2
- Regulation: 21 CFR 872.3640
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 8 generations back to K894595 (1990). 18 ancestors in all.
2 later devices descend from it; 1 cites it directly.
0 of 21 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K181137: IT-III active System, Neobiotech Co., Ltd. (2018) Summary page 4.

## Most influential descendants
- K242753: SD TL Implant System (2025), 1 descendant of its own
- K250280: SD TL Implant System (2025), 0 descendants of its own

## Indications for use
SNUCONE Tissue Level Implant System is indicated for use in paitially or fully edentulous mandibles and maxillae, in support of single or multiple-unit restorations including; cemented retained, or overdenture restorations and terminal or inte1mediate Abutment support for fixed bridge work. Snucone implant system is dedicated for two stage surgical procedures and for immediate loading when there is good primary stability and an appropriate occlusal load. Also, implants with diameters larger than 5mm are indicated for molar regions.

Source page: https://510kreport.com/device/K222792
Methodology: https://510kreport.com/methodology